Endoscopic sleeve gastroplasty obesity trial enters recruiting stage — LiveFuture News
Open on LiveFuture.ai →

Endoscopic sleeve gastroplasty obesity trial enters recruiting stage

The EGO-Trial is recruiting adults with obesity for endoscopic sleeve gastroplasty, with total body weight loss tracked at inclusion and 24 months after the procedure.

A study of endoscopic sleeve gastroplasty for obesity is now recruiting, which matters because it points to another live test of a procedure used to help adults with obesity. The trial is titled Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial), and the registry status is RECRUITING as of 2026-11-06T00:00:00+00:00.

The sponsor named in the registry is IHU Strasbourg. The record does not state a phase, and it lists primary completion as 2030-03, estimated. That means this is still an early-to-mid study timeline rather than a finished one.

"This record describes a study and its registry status; study outcomes require posted results."

What the trial is studying

The intervention is Endoscopic sleeve gastroplasty, with the study group described as all adult patients with obesity scheduled for endoscopic gastroplasty (ESG). In plain terms, the trial is focused on people already lined up for the procedure, rather than a broader or unrelated population.

Its main outcome is Total Body Weight Loss. The registry says this will be assessed at inclusion and 24 months after the procedure, with the description calling it an assessment of weight loss in terms of total body weight loss (TBWL, %) 24 months after surgery.

Why the timing matters

Because the primary completion date is estimated for 2030-03, readers should treat this as a study in progress, not a source of results. The registry also says has_results is false, so there are no posted outcomes to interpret yet.

That makes the current update simple but important: the trial is open, the procedure is defined, and the main question is how much body weight loss is seen over time. For people following obesity research, that is the kind of study detail that helps show where the field is heading, even before any findings appear.

Where this fits in obesity research

This trial sits inside the Obesity & Metabolic special event, alongside other obesity-related registry observations, including studies of drugs, surgery-related care, and lifestyle approaches. The common thread is that obesity research is being tested from several angles at once.

If you want the broader theme, the special event page collects related obesity and metabolic studies in one place. That makes it easier to follow how procedure-based research like EGO-Trial fits alongside other active recruiting and not-yet-recruiting trials.